Cite
Radionuclide ventriculography phase analysis for risk stratification of patients undergoing cardiotoxic cancer therapy
MLA
David Hamilton, et al. “Radionuclide Ventriculography Phase Analysis for Risk Stratification of Patients Undergoing Cardiotoxic Cancer Therapy.” Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology, vol. 29, no. 2, Feb. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b3ecbfbfadc1b145b022b435d871cd02&authtype=sso&custid=ns315887.
APA
David Hamilton, K. A. Jones, W. Martin, C. A. Paterson, A. D. Small, Surajit Ray, N. E. R. Goodfield, & J. Robinson. (2020). Radionuclide ventriculography phase analysis for risk stratification of patients undergoing cardiotoxic cancer therapy. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology, 29(2).
Chicago
David Hamilton, K. A. Jones, W. Martin, C. A. Paterson, A. D. Small, Surajit Ray, N. E. R. Goodfield, and J. Robinson. 2020. “Radionuclide Ventriculography Phase Analysis for Risk Stratification of Patients Undergoing Cardiotoxic Cancer Therapy.” Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology 29 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b3ecbfbfadc1b145b022b435d871cd02&authtype=sso&custid=ns315887.